Frontlight ResearchEarly access
CompletedNo phase
Vitamin and Unsaturated Fatty Acid Supplements in Healthy and Uveitis Human Subjects
Key facts
- Who runs it
- Tianjin Medical University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 7 people enrolled
- Started
- 15 Jul 2024
- Ended
- 31 Oct 2024
- Type of study
- Interventional, 4 groups
- Treatments tested
- Vitamin A treatment
- Monounsaturated fatty acid mixture
- Polyunsaturated fatty acid mixture
- Fatty acid mixture
- Record updated
- 7 November 2024
Who can take part
- Age
- 19 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- healthy or with uveitis volunteers age 19-65 years
Who cannot take part
- abnormal blood glucose, blood pressure, blood lipids, or other systemic diseases should not participate in the study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if dietary supplements containing vitamin and unsaturated fatty acid works to intervene T cell inflammatory factor expression in patients with uveitis and healthy subjects in adults.
The 4 groups in the trial
- Vitamin A treatmentTreatment being tested
- Monounsaturated fatty acid mixtureTreatment being tested
- Polyunsaturated fatty acid mixtureTreatment being tested
- Fatty acid mixtureTreatment being tested
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Interventional Study on the Treatment of Uveitis With Vitamin and Unsaturated Fatty Acid Combination Dietary Supplements Through Modulating T Cell Function
- Record updated
- 7 November 2024